Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder

Objective The COVID-19 pandemic has exacerbated health disparities, particularly among at-risk people with opioid use disorder (OUD) We sought to characterize the direct and indirect impacts of COVID-19 on this group to understand how the pandemic has affected this group, this group's public health response to COVID-19, and whether there were differences by race/ethnicity Methods This study recruited its sample from a drug treatment setting in the northeast region of the United States We surveyed 110 individuals on methadone as treatment for OUD and assessed COVID-19-related impacts on their health behaviors and other indices of social, physical, and mental well-being, including sexual health behaviors, substance use, mental health status, health care access, income, and employment Results Our findings highlight overall increases in depression, anxiety, loneliness, and frustration among the sample of people with OUD;the study also observed decreases in financial stability Significant differences between groups indicated a greater financial burden among racial-ethnic minorities;this subgroup also reported greater direct adverse effects of COVID-19, including being more concerned about contracting COVID-19, not being able to get a COVID-19 test, and knowing someone who had died from COVID-19 A greater proportion of Whites indicated increases in alcohol consumption and non–prescription drug use than did racial-ethnic minorities Conclusions Treatment providers must be vigilant in managing direct and indirect outcomes of COVID-19 among people with OUD Findings highlight the need to develop culturally competent, differentiated interventions in partnership with community-based organizations to meet the unique challenges that the COVID-19 pandemic presents for people in treatment for OUD